Search research articles
Contact Us
Filters
Showing results (151-160 of 191) with videos related to
Page
of 20
Sort By:
Cancers
|
January 8, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
Translational Oncology
|
August 19, 2022
The aberrant cancer metabolic gene carbohydrate sulfotransferase 11 promotes non-small cell lung cancer cell metastasis via dysregulation of ceruloplasmin and intracellular iron balance
Wei-Min Chang, Li-Jie Li, I-An Chiu, et al.
Cancer Research
|
September 25, 2012
Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3
Yi-Hua Jan, Hong-Yuan Tsai, Chih-Jen Yang, et al.
BMJ Open
|
March 21, 2023
Role of single-dose intravenous iron therapy for the treatment of anaemia after orthopaedic trauma: protocol for a pilot randomised controlled trial
Danielle F Peterson, Natasha S McKibben, Catherine E Hutchison, et al.
Anticancer Research
|
January 30, 2026
First-Line Afatinib 30 mg <i>Versus</i> 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan
Hui-Yang Hung, Tai-Huang Lee, Cheng-Hao Chuang, et al.
Journal of Clinical Medicine
|
October 13, 2021
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, et al.
Journal of Clinical Medicine
|
June 24, 2022
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis
Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function
Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 2024
<b>Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet </b>
Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Journal of Medicinal Food
|
February 9, 2010
Antiproliferative and antitumorigenic activity of Toona sinensis leaf extracts in lung adenocarcinoma
Chih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 191) with videos related to
Sort By:
Page
of 20
Cancers
|
January 8, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
Translational Oncology
|
August 19, 2022
The aberrant cancer metabolic gene carbohydrate sulfotransferase 11 promotes non-small cell lung cancer cell metastasis via dysregulation of ceruloplasmin and intracellular iron balance
Wei-Min Chang, Li-Jie Li, I-An Chiu, et al.
Cancer Research
|
September 25, 2012
Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3
Yi-Hua Jan, Hong-Yuan Tsai, Chih-Jen Yang, et al.
BMJ Open
|
March 21, 2023
Role of single-dose intravenous iron therapy for the treatment of anaemia after orthopaedic trauma: protocol for a pilot randomised controlled trial
Danielle F Peterson, Natasha S McKibben, Catherine E Hutchison, et al.
Anticancer Research
|
January 30, 2026
First-Line Afatinib 30 mg <i>Versus</i> 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan
Hui-Yang Hung, Tai-Huang Lee, Cheng-Hao Chuang, et al.
Journal of Clinical Medicine
|
October 13, 2021
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, et al.
Journal of Clinical Medicine
|
June 24, 2022
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis
Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function
Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 2024
<b>Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet </b>
Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Journal of Medicinal Food
|
February 9, 2010
Antiproliferative and antitumorigenic activity of Toona sinensis leaf extracts in lung adenocarcinoma
Chih-Jen Yang, Yu-Jung Huang, Cheng-Yuan Wang, et al.
Page
of 20